Cargando…
The Early Outcomes of Nurse Case Management in Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator: A Prospective Randomized Controlled Trial
BACKGROUND: Intravenous recombinant tissue plasminogen activator (i.v. rt-PA) is the milestone treatment for patients with acute ischemic stroke. Stroke Fast Track (SFT) facilitates time reduction, guarantees safety, and promotes good clinical outcomes in i.v. rt-PA treatment. Nursing case managemen...
Autores principales: | Kummarg, Urai, Sindhu, Siriorn, Muengtaweepongsa, Sombat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011075/ https://www.ncbi.nlm.nih.gov/pubmed/29977617 http://dx.doi.org/10.1155/2018/1717843 |
Ejemplares similares
-
Not only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator
por: Muengtaweepongsa, Sombat, et al.
Publicado: (2017) -
Stroke Outcomes in Thai Elderly Patients Treated with and without Intravenous Thrombolysis
por: A. Dharmasaroja, Pornpatr, et al.
Publicado: (2013) -
Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
por: Joo, Heesoo, et al.
Publicado: (2017) -
Hypothermia treatment reduced cyclin-dependent kinase 5-mediated inflammation in ischemic stroke and improved outcomes in ischemic stroke patients
por: Muengtaweepongsa, Sombat, et al.
Publicado: (2020) -
Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)